Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pATG versus basiliximab induction in first kidney transplantation
ChiCTR2400086400Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of antithymocyte globulin rabbit and basiliximab in kidney transplant (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Incidence, timing, and histological severity of acute rejection within 6 months after transplantation. Started Jul 2024; status: recruiting.
02
Drugs
antithymocyte globulin rabbitbasiliximab
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR2400086400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086400.